Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression
Andrew S. Luksik, Eli Yazigi, Pavan P. Shah, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1414-1414
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

The tumour microenvironment, treatment resistance and recurrence in glioblastoma
Jasmine White, Madeleine P. J. White, Agadha Wickremesekera, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives
Ilaria Salvato, Antonio Marchini
Cancers (2024) Vol. 16, Iss. 7, pp. 1276-1276
Open Access | Times Cited: 17
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Overcoming Barriers in Glioblastoma—Advances in Drug Delivery Strategies
Esther ter Linden, Erik R. Abels, Thomas S. van Solinge, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 998-998
Open Access | Times Cited: 9
Glioma–Immune Cell Crosstalk in Tumor Progression
Mahmoud Elguindy, Jacob S. Young, Isha Mondal, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 308-308
Open Access | Times Cited: 8
CAR-T State of the Art and Future Challenges, A Regulatory Perspective
Lorenzo Giorgioni, Alessandra Ambrosone, Maria Francesca Cometa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11803-11803
Open Access | Times Cited: 19
rWTC‐MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells
Herui Wang, Rogelio Medina, Juan Ye, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 7
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7
From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review
Moksada Regmi, Yingjie Wang, Weihai Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives
Megan Montoya, Marco Gallus, Su Phyu, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 726-726
Open Access | Times Cited: 6
CAR-T Cells Therapy in Glioblastoma: A Systematic Review on Molecular Targets and Treatment Strategies
Edoardo Agosti, Alexandru Garaba, Sara Antonietti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7174-7174
Open Access | Times Cited: 6
Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
Khubaib Ali, Muhammad Nabeel, Fatima Mohsin, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access | Times Cited: 5
Addressing the Blood-Brain Barrier: Overcoming Glioblastoma Drug Delivery
Ly Porosk, Ülo Langel
Methods in pharmacology and toxicology (2025), pp. 83-104
Closed Access
Why Do Glioblastoma Treatments Fail?
Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, et al.
Future Pharmacology (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Timely administration of drug combination improves chemoimmunotherapy of an immune-cold tumor
Fanfei Meng, Yanying He, Jiaqi Zhao, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113579-113579
Closed Access
Unravelling the modified T cell receptor through Gen-Next CAR T cell therapy in Glioblastoma: Current status and future challenges
Bhavya Bhutani, Vinay Sharma, Nirmal Kumar Ganguly, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117987-117987
Closed Access
Gliomas in adults: Guidance on Investigations, Diagnosis, Treatment & Surveillance
Anna Lerner, Kieran Palmer, Tom Campion, et al.
Clinical Medicine (2024) Vol. 24, Iss. 5, pp. 100240-100240
Open Access | Times Cited: 4
Immune Resistance in Glioblastoma: Understanding the Barriers to ICI and CAR-T Cell Therapy
Thomas Eckert, M. S. Zobaer, Jessie Boulos, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 462-462
Open Access
Knowledge structures and research hotspots of immunotherapy for brain metastasis, glioma, meningioma, and pituitary adenoma: A bibliometric and visualization review
Donghu Yu, Jin Wang, Lei Hu, et al.
Chinese Chemical Letters (2025), pp. 110995-110995
Closed Access
Opportunities to Modulate Tumor Ecosystem Toward Successful Glioblastoma Immunotherapy
Mariko Takahashi, Darina Mukhamejanova, Himani Jasewicz, et al.
Cancer Science (2025)
Open Access
The Role of Gut Microbiome on Glioblastoma Oncogenesis and Malignant Evolution
Zahurin Mohamed, Qiong Wu, Maria A. Jacome, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2935-2935
Open Access
Cell therapies against brain tumors: Clinical development and emerging prospects
Tatsuya Fukuta, Suyog Shaha, Andrés da Silva‐Candal, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Glioblastoma Tumor Microenvironment: An Important Modulator for Tumoral Progression and Therapy Resistance
Ligia Gabriela Tătăranu, Șerban Turliuc, A. El Kamel, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 9881-9894
Open Access | Times Cited: 3
EGFRVIII and EGFR targeted chimeric antigen receptor T cell therapy in glioblastoma
Robert C. Sterner, Rosalie M. Sterner
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Immune Escape in Glioblastoma: Mechanisms of Action and Implications for Immune Checkpoint Inhibitors and CAR T-Cell Therapy
Catherine Yu, Kristin Hsieh, Daniel R. Cherry, et al.
Biology (2023) Vol. 12, Iss. 12, pp. 1528-1528
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top